Wednesday, November 15, 2017 8:04:41 AM
JAGX - .2094 Pre-market now at .23/.24
Year-to-Date Gross Sales for Mytesi, the FDA-Approved Human Prescription Drug Product of Jaguar Health's Wholly-Owned Subsidiary, Napo Pharmaceuticals, Total $2.8 Million
Year-to-Date Gross Sales for Mytesi, the FDA-Approved Human Prescription Drug Product of Jaguar Health's Wholly-Owned Subsidiary, Napo Pharmaceuticals, Total $2.8 Million
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
